Dr. Daniel Heikali, MD

Dr. Heikali practices at Adventist Health White Memorial in Los Angeles, California, part of Adventist Health.

Dr. Heikali's NPI, 1578958724, was assigned on April 4, 2015. Dr. Heikali graduated from UC Irvine School of Medicine in 2015. Dr. Heikali holds California license A146329.

Dr. Heikali's primary practice is Adventist Health White Memorial, at 1720 Cesar E Chavez Avenue, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 268-5000.

Dr. Heikali's primary practice is Adventist Health White Memorial in Los Angeles, California, part of Adventist Health. The medical group on file is Boyle Heights Cardiovascular Medical Group. Dmand AI also links Dr. Heikali to 1 more group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heikali practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Heikali's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Heikali is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Heikali is licensed in California.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Heikali treats.

CMS data shows 1,448 Medicare services from Dr. Heikali across 13 procedure codes in 2024, for 385 Medicare patients. Medicare paid $135,190 for them.

CMS counts 385 Medicare patients who saw Dr. Heikali in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have diabetes, and 75% have high blood pressure. 86% are also on Medicaid. Their average risk score is 3.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Heikali's median patient age at 69, with 47% women.

In 2024, Dr. Heikali wrote 1,406 Medicare Part D claims for 320 patients. 86% of them were for generic drugs. CMS names the drug for 1,224 of them, across 24 drugs with 11 or more claims each, at $163,114 in total drug cost. In 2023, CMS named 290 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Heikali for performance year 2024, reported as part of a group. Dr. Heikali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of coronary angioplasty and stenting by Dr. Heikali, more than 86% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Heikali in 2017. Dr. Heikali's most frequent co-authors are Saif Al Yaseen, MD, John James Hollowed, MD and Michael S. Lee, MD.

CMS Open Payments shows 249 general payments to Dr. Heikali from 24 drug and device companies from 2018 to 2025. Grants make up the largest share, 70% of the total. Medtronic, Inc. paid the most, $15,306.

Dr. Heikali graduated from UC Irvine School of Medicine in 2015.

Dr. Heikali is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.